J Gastiaburu

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

D. Machover, Eduardo Díaz‐Rubio, Aimery de Gramont et al. · Annals of Oncology · 1996 · 434 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Chronomodulated Versus Fixed-Infusion—Rate Delivery of Ambulatory Chemotherapy With Oxaliplatin, Fluorouracil, and Folinic Acid (Leucovorin) in Patients With Colorectal Cancer Metastases: a Randomized Multi-institutional Trial

Françis Lévi, Rachid Zidani, Jean-Michel Vannetzel et al. · JNCI Journal of the National Cancer Institute · 1994 · 396 citations

Medicine, Oncology, Pharmacology +16

Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate

Francis Lévi, B Perpoint, Carlo Garufi et al. · European Journal of Cancer · 1993 · 216 citations

Medicine, Oncology, Pharmacology +17

Pharmacokinetics of oxaliplatin in patients with normal versus impaired renal function

Claire Massari, S. Brienza, Mathieu Rotarski et al. · Cancer Chemotherapy and Pharmacology · 2000 · 97 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC)

I. Monnet, S. Brienza, F. Hugret et al. · European Journal of Cancer · 1998 · 72 citations

Medicine, Oncology, Pharmacology +13